CR Bard Transvaginal Mesh Lawsuit Docs Show Avaulta Mesh May Have Been Constructed with Plastic Unsuitable for Humans
Emails recently unsealed in the federal CR Bard transvaginal mesh lawsuit litigation underway in the Southern District of West Virginia reveal that some of the company’s Avaulta mesh devices contained a plastic that its manufacturer warned was not appropriate for implantation in humans.
These emails, which were authored by an executive with Bard’s Davol unit in 2004 and 2007, alerted colleagues against revealing to Chevron Phillips Chemical Co. that its resin-based plastic was being used in hernia-repair mesh devices, according to Bloomberg.com. In fact, in March 2004, the Davol executive—now, a vice president at C.R. Bard—wrote, “It is likely they do not know of our implant application. Please do not mention Davol’s name in any discussion with these manufacturers.”
Vaginal mesh attorneys who represent women in Bard Avaulta mesh lawsuits claim company officials were aware of the potential dangers associated with this material, but kept that information a secret, according to Bloomberg.com.
C.R. Bard Named in Over 4,000 Transvaginal Mesh Lawsuits
This information may have an impact on the thousands of federally-filed transvaginal mesh lawsuits pending in the C.R. Bard multidistrict litigation (MDL) underway in the U.S. District Court, Southern District of West Virginia. According to a Case List updated June 25th, 3,776 claims had been filed in the proceeding; the first bellwether trial is scheduled to begin in July. All of the lawsuits allege C.R. Bard’s Avaulta vaginal mesh devices have the potential to cause mesh erosion, chronic pain, infection, and other serious injuries.
Claims brought against transvaginal mesh manufacturers, including American Medical Systems, Johnson & Johnson’s Ethicon unit, and Boston Scientific, have been filed in separate MDLs that have also been established in the Southern District of West Virginia. At the state level, court documents reveal that some 550 similar claims against C.R. Bard have been consolidated in a litigation established in New Jersey’s Atlantic County Superior Court as of June 8, 2013.
Contact a Transvaginal Mesh Lawyer Today
Women who suffered mesh erosion, chronic pain, scarring, infections or other transvaginal mesh complications following implantation of a C.R. Bard Avaulta device may be entitled to compensation from the company. Our attorneys are offering free legal consultations to women injured by these products. For more information, call our law firm as soon as possible at 1-888-217-3033.